team meeting


Solving the specialty drug challenge requires a new model for management and a disruptive partner willing to challenge the status quo.

The Specialty Drug Challenge


Employers are experiencing alarming increases in drug spend.


Most payers only manage drug discounts and rebates.

Meaningful savings result from a focus on value and appropriate use.

Specialty PBM

Take back control of your benefit. 

Archimedes is helping plan sponsors address the rising cost of specialty medications through our unique specialty drug PBM solution.

  • Moves management of specialty drug benefit away from the traditional PBM.
  • Applies rigorous clinical and cost management programs uniquely designed for high cost specialty patients.
  • Utilizes Archimedes’ formulary to optimize appropriate use and lowest net cost
fish jumping out of bowl

Medical Specialty Drug Management

Specialty medications coming through the medical benefit represent 40% of specialty spend, yet are often minimally managed with little to no visibility for employers.

Archimedes’ MEDiQ addresses the inherent limitations with managing these high cost drugs to deliver significant savings for clients.

  • Robust clinical management including rigorous prior authorization, promotion of first-line therapies and biosimilar first policy
  • Interventions to optimize channel and sites of care for infusions.
  • Medical claims editing and monitoring for billing errors.
  • Powered by a proprietary technology that provides state-of-the-art algorithms for identifying waste on medical specialty drugs
test tubes and beakers
Rheumatoid Arthritis
Crohn's Disease
Uncompromising rigor in our coverage approach and clinical programs
Hereditary Angioedema
Multiple Sclerosis
female sitting and smiling in front of orange background
Hepatitis C
Hormone Deficiency
pills in the shape of an 'S'
Cystic Fibrosis
team meeting

What We Believe

100% Client Revenue

PBMs should make 100% of their revenue from fees paid directly by their clients. This alignment of financial interests between the PBM and client is essential to managing costs.

Lowest Net Cost

Coverage should be based on lowest net cost and value, not on rebate maximization or optimizing the profits of the PBM-owned pharmacy.


Full visibility of performance metrics is a critical foundation to holding the PBM accountable.

Learn how Archimedes can help you address the rising cost of specialty medications across the medical and pharmacy benefits.

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now